CORT Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 20.50%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $21,089,939.58

Corcept Therapeutics Insider Trading History Chart

Corcept Therapeutics Share Price & Price History

^$69.37

▲ +4.69 (7.25%)

As of 04/23/2025 04:58 PM ET

Days: 30 | 90 | 365

Corcept Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/10/2025	Daniel N. Swisher, Jr.	Director	Sell	2,200	$70.22	$154,484.00
3/31/2025	Joseph K. Belanoff	CEO	Sell	35,102	$94.72	$3,324,861.44	2,982,335
3/31/2025	Sean Maduck	Insider	Sell	100,000	$100.54	$10,054,000.00	85,622
3/24/2025	Joseph Douglas Lyon	Insider	Sell	421	$60.58	$25,504.18	9,009
3/24/2025	Joseph K. Belanoff	CEO	Sell	1,974	$60.83	$120,078.42	3,017,437
3/3/2025	Joseph K. Belanoff	CEO	Sell	2,924	$60.91	$178,100.84	3,019,411
3/3/2025	Sean Maduck	Insider	Sell	18,303	$60.69	$1,110,809.07	85,622
2/10/2025	Daniel N. Swisher, Jr.	Director	Sell	2,200	$68.08	$149,776.00
1/10/2025	Daniel N. Swisher, Jr.	Director	Sell	2,200	$50.54	$111,188.00
1/2/2025	Sean Maduck	Insider	Sell	20,000	$50.39	$1,007,800.00	85,318
12/10/2024	Daniel N. Swisher, Jr.	Director	Sell	2,200	$59.46	$130,812.00
11/22/2024	Joseph Douglas Lyon	Insider	Sell	1,411	$56.72	$80,031.92	8,494
11/11/2024	Daniel N. Swisher, Jr.	Director	Sell	2,200	$59.88	$131,736.00
11/4/2024	William Guyer	Insider	Sell	3,394	$48.97	$166,204.18	5,796
11/1/2024	William Guyer	Insider	Sell	6,606	$48.97	$323,495.82	5,796
10/1/2024	Gary Charles Robb	Insider	Sell	11,000	$46.28	$509,080.00	22,772
9/3/2024	William Guyer	Insider	Sell	10,000	$35.30	$353,000.00	6,039
8/26/2024	Gary Charles Robb	Insider	Sell	3,101	$35.71	$110,736.71	23,190
8/1/2024	Daniel N. Swisher, Jr.	Director	Sell	150	$38.50	$5,775.00
8/1/2024	William Guyer	Insider	Sell	10,000	$38.67	$386,700.00	6,039
7/1/2024	Daniel N. Swisher, Jr.	Director	Sell	2,200	$32.81	$72,182.00
7/1/2024	Joseph Douglas Lyon	Insider	Sell	5,000	$32.49	$162,450.00	9,290
6/3/2024	Daniel N. Swisher, Jr.	Director	Sell	2,200	$30.21	$66,462.00
6/3/2024	Joseph Douglas Lyon	Insider	Sell	5,000	$30.18	$150,900.00	7,314
5/28/2024	Gary Charles Robb	Insider	Sell	11,000	$30.39	$334,290.00	20,203
5/13/2024	Sean Maduck	Insider	Sell	50,000	$28.00	$1,400,000.00	85,222
5/9/2024	Joseph Douglas Lyon	Insider	Sell	7,227	$26.00	$187,902.00	7,314
5/2/2024	Joseph Douglas Lyon	Insider	Sell	10,830	$26.00	$281,580.00	7,314
4/4/2024	Joseph Douglas Lyon	Insider	Sell	5,443	$26.00	$141,518.00	7,314
4/1/2024	Daniel N. Swisher, Jr.	Director	Sell	2,200	$25.30	$55,660.00
4/1/2024	Joseph Douglas Lyon	Insider	Sell	500	$26.01	$13,005.00	7,314
3/27/2024	Sean Maduck	Insider	Sell	25,953	$25.01	$649,084.53	85,222
3/18/2024	Sean Maduck	Insider	Sell	17,219	$25.00	$430,475.00	75,222
3/1/2024	Daniel N. Swisher, Jr.	Director	Sell	2,200	$23.59	$51,898.00
2/16/2024	Joseph Douglas Lyon	CAO	Sell	1,000	$26.00	$26,000.00	6,774
2/16/2024	Sean Maduck	Insider	Sell	27,068	$25.97	$702,955.96	74,455
2/1/2024	Daniel N. Swisher, Jr.	Director	Sell	2,200	$22.00	$48,400.00
1/2/2024	Daniel N. Swisher, Jr.	Director	Sell	2,200	$22.11	$48,642.00
12/22/2023	William Guyer	Insider	Sell	10,000	$32.00	$320,000.00	6,643
12/5/2023	Gary Charles Robb	Insider	Sell	1,381	$26.27	$36,278.87	27,602
12/4/2023	Joseph Douglas Lyon	CAO	Sell	2,432	$26.00	$63,232.00	5,854
12/1/2023	Daniel N. Swisher, Jr.	Director	Sell	2,200	$25.47	$56,034.00
12/1/2023	Joseph Douglas Lyon	CAO	Sell	2,568	$26.00	$66,768.00	5,854
12/1/2023	Sean Maduck	Insider	Sell	25,000	$25.56	$639,000.00	73,291
11/2/2023	Joseph Douglas Lyon	CAO	Sell	3,977	$28.11	$111,793.47	5,854
11/1/2023	Daniel N. Swisher, Jr.	Director	Sell	2,200	$27.96	$61,512.00
11/1/2023	Sean Maduck	Insider	Sell	5,112	$28.08	$143,544.96	73,291
10/10/2023	Sean Maduck	Insider	Sell	18,471	$27.29	$504,073.59	73,291
10/6/2023	Joseph Douglas Lyon	CAO	Sell	2,582	$27.24	$70,333.68	5,854
10/6/2023	Sean Maduck	Insider	Sell	3,498	$27.24	$95,285.52	73,610
10/2/2023	Daniel N. Swisher, Jr.	Director	Sell	2,200	$27.32	$60,104.00
10/2/2023	Joseph Douglas Lyon	CAO	Sell	2,418	$27.25	$65,890.50	5,854
10/2/2023	Sean Maduck	Insider	Sell	3,031	$27.24	$82,564.44	73,610
9/19/2023	Sean Maduck	Insider	Sell	25,000	$32.48	$812,000.00	73,610
9/5/2023	Daniel N. Swisher, Jr.	Director	Sell	2,200	$32.90	$72,380.00
9/1/2023	Daniel N. Swisher, Jr.	Director	Sell	1,550	$32.73	$50,731.50
9/1/2023	Joseph Douglas Lyon	CAO	Sell	5,000	$32.73	$163,650.00	5,132
8/21/2023	Joseph Douglas Lyon	CAO	Sell	4,588	$31.19	$143,099.72	5,132
8/14/2023	David L. Mahoney	Director	Sell	25,000	$30.95	$773,750.00	11,297
8/14/2023	Hazel Hunt	Insider	Sell	20,455	$30.89	$631,854.95	73,146
8/7/2023	Daniel N. Swisher, Jr.	Director	Sell	2,850	$30.14	$85,899.00
8/7/2023	Joseph Douglas Lyon	CAO	Sell	412	$31.22	$12,862.64	4,720
6/6/2023	Joseph Douglas Lyon	CAO	Sell	10,000	$23.60	$236,000.00	5,132
5/9/2023	Gary Charles Robb	Insider	Sell	30,000	$23.87	$716,100.00	33,997
12/1/2022	Sean Maduck	Insider	Sell	625	$25.28	$15,800.00	56,462
11/22/2022	Gary Charles Robb	Insider	Sell	4,814	$26.03	$125,308.42	21,329
11/17/2022	Gary Charles Robb	Insider	Sell	10,000	$26.06	$260,600.00	39,544
11/10/2022	Sean Maduck	Insider	Sell	25,000	$25.57	$639,250.00	56,462
10/3/2022	Sean Maduck	Insider	Sell	25,000	$25.64	$641,000.00	56,462
9/7/2022	Gary Charles Robb	Insider	Sell	50,000	$26.06	$1,303,000.00	49,544
8/9/2022	Sean Maduck	Insider	Sell	200	$28.70	$5,740.00	40,024
7/18/2022	Sean Maduck	Insider	Sell	25,000	$27.37	$684,250.00	40,024
7/6/2022	Gary Charles Robb	Insider	Sell	45,000	$26.00	$1,170,000.00	24,123
7/6/2022	Joseph K. Belanoff	CEO	Sell	279,908	$26.27	$7,353,183.16	2,538,218
5/19/2022	Gary Charles Robb	Insider	Sell	6,127	$19.57	$119,905.39	36,446
5/17/2022	Gary Charles Robb	Insider	Sell	28,745	$19.55	$561,964.75	42,701

See Full Table

SEC Filings (Institutional Ownership Changes) for Corcept Therapeutics (NASDAQ:CORT)

93.61% of Corcept Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Corcept Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/23/2025	Robeco Institutional Asset Management B.V.	3,107	$0.36M	0.0%	N/A	0.003%
4/23/2025	Sequoia Financial Advisors LLC	3,362	$0.38M	0.0%	N/A	0.003%
4/23/2025	Balboa Wealth Partners	2,936	$0.34M	0.1%	-26.3%	0.003%
4/23/2025	Retirement Guys Formula LLC	3,147	$0.36M	0.2%	-29.2%	0.003%
4/23/2025	Oppenheimer & Co. Inc.	22,246	$2.54M	0.0%	+39.0%	0.021%
4/22/2025	Illumine Investment Management LLC	12,420	$1.42M	1.2%	-39.4%	0.012%
4/22/2025	Cambridge Investment Research Advisors Inc.	12,005	$1.37M	0.0%	-39.3%	0.011%
4/22/2025	Synergy Asset Management LLC	170,751	$19.50M	2.5%	-63.1%	0.162%
4/21/2025	Blue Trust Inc.	2,345	$0.27M	0.0%	-20.0%	0.002%
4/21/2025	Envestnet Portfolio Solutions Inc.	5,074	$0.58M	0.0%	N/A	0.005%
4/21/2025	Boston Trust Walden Corp	584,800	$66.80M	0.5%	-35.0%	0.554%
4/21/2025	State of Alaska Department of Revenue	51,669	$5.90M	0.1%	-2.5%	0.049%
4/21/2025	CWA Asset Management Group LLC	19,802	$2.26M	0.1%	+21.6%	0.019%
4/21/2025	Roman Butler Fullerton & Co.	3,354	$0.38M	0.1%	-87.3%	0.003%
4/17/2025	QRG Capital Management Inc.	96,923	$11.07M	0.1%	+0.6%	0.092%
4/17/2025	Exchange Traded Concepts LLC	8,985	$1.03M	0.0%	-3.7%	0.009%
4/16/2025	Campbell Newman Asset Management Inc.	32,985	$3.77M	0.3%	-32.9%	0.031%
4/16/2025	Wealth Enhancement Advisory Services LLC	7,954	$0.91M	0.0%	+3.0%	0.008%
4/16/2025	Goldstone Financial Group LLC	4,786	$0.55M	0.1%	N/A	0.005%
4/15/2025	SG Americas Securities LLC	43,109	$4.92M	0.0%	+285.3%	0.041%
4/15/2025	Livforsakringsbolaget Skandia Omsesidigt	2,000	$0.23M	0.0%	N/A	0.002%
4/15/2025	GAMMA Investing LLC	3,407	$0.39M	0.0%	+13.7%	0.003%
4/14/2025	Yousif Capital Management LLC	27,201	$3.11M	0.0%	-2.7%	0.026%
4/14/2025	Bridge City Capital LLC	42,029	$4.80M	1.4%	-27.4%	0.040%
4/14/2025	Pallas Capital Advisors LLC	4,014	$0.46M	0.0%	N/A	0.004%
4/14/2025	First Citizens Bank & Trust Co.	5,113	$0.58M	0.0%	N/A	0.005%
4/14/2025	Park Avenue Securities LLC	2,266	$0.26M	0.0%	N/A	0.002%
4/11/2025	Tealwood Asset Management Inc.	19,818	$2.26M	1.0%	N/A	0.019%
4/11/2025	Eagle Rock Investment Company LLC	3,000	$0.34M	0.1%	N/A	0.003%
4/11/2025	Intellectus Partners LLC	42,051	$4.80M	1.2%	-15.7%	0.040%
4/10/2025	Hennion & Walsh Asset Management Inc.	46,149	$5.27M	0.2%	-4.1%	0.044%
4/10/2025	Juncture Wealth Strategies LLC	5,538	$0.63M	0.2%	N/A	0.005%
4/9/2025	Merit Financial Group LLC	2,599	$0.30M	0.0%	N/A	0.002%
4/8/2025	Rhumbline Advisers	201,401	$23M	0.0%	+0.3%	0.191%
4/8/2025	Parallel Advisors LLC	3,972,416	$453.73M	9.7%	+3.7%	3.765%
4/7/2025	GAMMA Investing LLC	389,148	$44.45M	0.0%	+12,888.9%	0.369%
4/2/2025	Marcum Wealth LLC	4,711	$0.54M	0.0%	-49.8%	0.004%
4/1/2025	MassMutual Private Wealth & Trust FSB	620	$71K	0.0%	+102.0%	0.001%
3/24/2025	Wellington Management Group LLP	37,719	$1.90M	0.0%	-8.2%	0.036%
3/18/2025	California State Teachers Retirement System	86,974	$4.38M	0.0%	-0.8%	0.082%
3/17/2025	Wealth Enhancement Advisory Services LLC	7,724	$0.39M	0.0%	+50.1%	0.007%
3/3/2025	Cim LLC	12,300	$0.62M	0.1%	-20.4%	0.012%
2/20/2025	Mackenzie Financial Corp	6,207	$0.31M	0.0%	-3.7%	0.006%
2/19/2025	Cache Advisors LLC	7,500	$0.38M	0.1%	N/A	0.007%
2/19/2025	Public Employees Retirement System of Ohio	2,859	$0.14M	0.0%	+269.9%	0.003%
2/18/2025	Vise Technologies Inc.	4,046	$0.20M	0.0%	N/A	0.004%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	224,713	$11.32M	0.0%	+11.1%	0.214%
2/17/2025	Voloridge Investment Management LLC	471,623	$23.77M	0.1%	-24.2%	0.450%
2/17/2025	Vident Advisory LLC	109,778	$5.53M	0.1%	-5.3%	0.105%
2/17/2025	Two Sigma Advisers LP	381,800	$19.24M	0.0%	-16.5%	0.364%
2/17/2025	Two Sigma Investments LP	202,528	$10.21M	0.0%	-43.1%	0.193%
2/17/2025	Teza Capital Management LLC	4,210	$0.21M	0.0%	N/A	0.004%
2/17/2025	Tanaka Capital Management Inc.	111,551	$5.62M	12.9%	-0.5%	0.106%
2/17/2025	Sherbrooke Park Advisers LLC	5,620	$0.28M	0.1%	N/A	0.005%
2/17/2025	Rafferty Asset Management LLC	5,906	$0.30M	0.0%	-48.7%	0.006%
2/17/2025	Raiffeisen Bank International AG	2,000	$0.10M	0.0%	N/A	0.002%
2/17/2025	ProShare Advisors LLC	24,596	$1.24M	0.0%	+43.8%	0.023%
2/17/2025	Quantedge Capital Pte Ltd	4,800	$0.24M	0.1%	N/A	0.005%
2/17/2025	Man Group plc	287,880	$14.51M	0.0%	-17.9%	0.275%
2/17/2025	Nuveen Asset Management LLC	220,679	$11.12M	0.0%	-0.6%	0.211%
2/17/2025	Occudo Quantitative Strategies LP	5,600	$0.28M	0.1%	N/A	0.005%
2/17/2025	OMERS ADMINISTRATION Corp	44,500	$2.24M	0.0%	-54.3%	0.042%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	46,033	$2.32M	0.0%	+4.0%	0.044%
2/17/2025	Lazard Asset Management LLC	20,000	$1.01M	0.0%	+7.6%	0.019%
2/17/2025	Jacobs Levy Equity Management Inc.	1,376,881	$69.38M	0.2%	+12.5%	1.314%
2/17/2025	Janus Henderson Group PLC	301,490	$15.19M	0.0%	-7.0%	0.288%
2/17/2025	Gen Wealth Partners Inc	1,325	$67K	0.0%	N/A	0.001%
2/17/2025	Gotham Asset Management LLC	19,137	$0.96M	0.0%	+2.8%	0.018%
2/17/2025	Graham Capital Management L.P.	13,281	$0.67M	0.0%	-38.2%	0.013%
2/17/2025	Focus Partners Wealth	33,073	$1.67M	0.0%	+2.1%	0.032%
2/17/2025	Ensign Peak Advisors Inc	47,929	$2.42M	0.0%	+29.9%	0.046%
2/17/2025	Deutsche Bank AG	73,600	$3.71M	0.0%	+48.5%	0.070%
2/17/2025	D. E. Shaw & Co. Inc.	886,576	$44.68M	0.0%	+12.5%	0.846%
2/17/2025	EP Wealth Advisors LLC	7,000	$0.35M	0.0%	+7.3%	0.007%
2/17/2025	Corton Capital Inc.	5,904	$0.30M	0.2%	N/A	0.006%
2/17/2025	Cresset Asset Management LLC	99,975	$5.04M	0.0%	+23.3%	0.095%
2/17/2025	Crestline Management LP	13,774	$0.69M	0.0%	+50.4%	0.013%
2/17/2025	Cetera Investment Advisers	22,048	$1.11M	0.0%	-18.6%	0.021%
2/17/2025	Centiva Capital LP	5,419	$0.27M	0.0%	N/A	0.005%
2/17/2025	Bosun Asset Management LLC	7,095	$0.36M	0.2%	N/A	0.007%
2/17/2025	Brevan Howard Capital Management LP	8,423	$0.42M	0.0%	N/A	0.008%
2/17/2025	Capstone Investment Advisors LLC	8,862	$0.45M	0.0%	-91.5%	0.008%
2/17/2025	Captrust Financial Advisors	113,988	$5.74M	0.0%	+9.9%	0.109%
2/17/2025	Caxton Associates LP	10,632	$0.54M	0.0%	N/A	0.010%
2/17/2025	Balyasny Asset Management L.P.	9,480	$0.48M	0.0%	-27.0%	0.009%
2/17/2025	Bayesian Capital Management LP	6,087	$0.31M	0.0%	N/A	0.006%
2/17/2025	Bank of America Corp DE	98,654	$4.97M	0.0%	-38.9%	0.094%
2/17/2025	BNP Paribas Financial Markets	57,830	$2.91M	0.0%	-42.2%	0.055%
2/17/2025	Ameriprise Financial Inc.	317,318	$15.99M	0.0%	-19.1%	0.303%
2/17/2025	Algert Global LLC	39,328	$1.98M	0.0%	-2.0%	0.038%
2/17/2025	Ancora Advisors LLC	16,188	$0.82M	0.0%	+2,653.1%	0.015%
2/17/2025	AXA S.A.	29,840	$1.50M	0.0%	+204.0%	0.028%
2/14/2025	FAS Wealth Partners Inc.	309,207	$15.58M	1.3%	-2.1%	0.295%
2/14/2025	Comerica Bank	38,641	$1.95M	0.0%	+1.6%	0.037%
2/14/2025	AQR Capital Management LLC	276,591	$13.94M	0.0%	-12.5%	0.264%
2/14/2025	Northern Trust Corp	1,015,515	$51.17M	0.0%	+10.2%	0.969%
2/14/2025	The Manufacturers Life Insurance Company	49,759	$2.51M	0.0%	-2.4%	0.047%
2/14/2025	Aquatic Capital Management LLC	34,534	$1.74M	0.0%	+104.3%	0.033%
2/14/2025	Susquehanna Fundamental Investments LLC	33,097	$1.67M	0.0%	N/A	0.032%
2/14/2025	Nebula Research & Development LLC	11,578	$0.58M	0.1%	N/A	0.011%

Data available starting January 2016

See Full Table

Corcept Therapeutics Incorporated engages in discovery and development of drugs for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States. It offers Korlym tablets medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous cushing's syndrome; and who have type 2 diabetes mellitus or glucose intolerance and have failed surgery or are not candidates for surgery. The company is also developing relacorilant, which is in phase III clinical trial for the treatment of cushing's syndrome; treatment for adrenal cancer and cortisol excess which is in phase 1b clinical trial; treatment for prostate cancer which is in phase II clinical trial; and nab-paclitaxel in combination with relacorilant, which is in phase III clinical trial to treat platinum-resistant ovarian tumors. In addition, it develops dazucorilant, which is in phase II clinical trial for the treatment of amyotrophic lateral sclerosis; miricorilant, which is in phase IIb trial for the treatment of nonalcoholic steatohepatitis; and treatment for antipsychotic induced weight gain that is in phase I trial. The company was incorporated in 1998 and is headquartered in Menlo Park, California.

Today's Range

Now: $69.37

$65.77

$70.73

50 Day Range

MA: $65.04

$54.30

$114.22

52 Week Range

Now: $69.37

$22.00

$117.33

Volume

1,799,771 shs

Average Volume

1,123,091 shs

Market Capitalization

$7.32 billion

P/E Ratio

55.06

Dividend Yield

N/A

Beta

0.15

Who are the company insiders with the largest holdings of Corcept Therapeutics?: Corcept Therapeutics' top insider investors include:
Joseph K Belanoff (CEO)
Sean Maduck (Insider)
Hazel Hunt (Insider)
Gary Charles Robb (Insider)
David L Mahoney (Director)
Joseph Douglas Lyon (Insider)
Joseph Douglas Lyon (CAO)
William Guyer (Insider)
Daniel N Swisher, Jr (Director)
Learn More about top insider investors at Corcept Therapeutics.
Who are the major institutional investors of Corcept Therapeutics?: Corcept Therapeutics' top institutional shareholders include:
Parallel Advisors LLC — 3.77%
Boston Trust Walden Corp — 0.55%
GAMMA Investing LLC — 0.37%
Rhumbline Advisers — 0.19%
Synergy Asset Management LLC — 0.16%
QRG Capital Management Inc. — 0.09%
Learn More about top institutional investors of Corcept Therapeutics stock.
Which institutional investors are selling Corcept Therapeutics stock?: During the last quarter, CORT stock was sold by these institutional investors:
Boston Trust Walden Corp
Synergy Asset Management LLC
Roman Butler Fullerton & Co.
Campbell Newman Asset Management Inc.
Bridge City Capital LLC
Illumine Investment Management LLC
Intellectus Partners LLC
Cambridge Investment Research Advisors Inc.
During the previous year, company insiders that have sold Corcept Therapeutics company stock include:
Joseph K Belanoff (CEO)
Sean Maduck (Insider)
Hazel Hunt (Insider)
Gary Charles Robb (Insider)
David L Mahoney (Director)
Joseph Douglas Lyon (Insider)
Learn More investors selling Corcept Therapeutics stock.
Which institutional investors are buying Corcept Therapeutics stock?: In the previous quarter, CORT stock was bought by institutional investors including:
GAMMA Investing LLC
Parallel Advisors LLC
SG Americas Securities LLC
Tealwood Asset Management Inc.
Oppenheimer & Co. Inc.
Juncture Wealth Strategies LLC
First Citizens Bank & Trust Co.
Envestnet Portfolio Solutions Inc.